Osimertinib after definitive chemoradiotherapy in unresectable stage III epidermal growth factor receptor-mutated non-small-cell lung cancer: analyses of central nervous system efficacy and distant progression from the phase III LAURA study ☆
Titel:
Osimertinib after definitive chemoradiotherapy in unresectable stage III epidermal growth factor receptor-mutated non-small-cell lung cancer: analyses of central nervous system efficacy and distant progression from the phase III LAURA study ☆
Auteur:
Lu, S. Ahn, M.-J. Reungwetwattana, T. Özgüroğlu, M. Kato, T. Yang, J.C.-H. Huang, M. Fujiki, F. Inoue, T. Quang, L.-V. Sriuranpong, V. Vicente, D. Fuentes, C. Chaudhry, A.A. Poole, L. Armenteros Monterroso, E. Rukazenkov, Y. van der Gronde, T. Ramalingam, S.S.